Boston Scientific said its Ingenio pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps) run the risk of incorrect transition to safety mode. In safety mode, there is a risk of inappropriate loss of pacing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,